Group One Trading
EGRX

Group One Trading’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Group One Trading’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-785
Closed -$2.93K – 8186
2024
Q3 		$2.93K Buy
+785
New +$3.75K ﹤0.01% 6051
2024
Q2 		– Sell
-285
Closed -$1.24K – 7677
2024
Q1 		$1.49K Sell
285
-3,796
-93% -$20.8K ﹤0.01% 6552
2023
Q4 		$21.3K Buy
+4,081
New +$40.3K ﹤0.01% 5704
2019
Q4 		– Sell
-552
Closed -$32.9K – 5736
2019
Q3 		$31K Buy
+552
New +$31K ﹤0.01% 4197
2019
Q1 		– Sell
-16,202
Closed -$721K – 5480
2018
Q4 		$653K Buy
+16,202
New +$835K 0.01% 1819
2018
Q2 		– Sell
-190
Closed -$12K – 5562
2018
Q1 		$10K Sell
190
-6,098
-97% -$355K ﹤0.01% 4326
2017
Q4 		$336K Buy
+6,288
New +$350K ﹤0.01% 2567
2017
Q1 		– Sell
-314
Closed -$23.3K – 5085
2016
Q4 		$25K Buy
+314
New +$22.8K ﹤0.01% 3615
2015
Q3 		– Sell
-100
Closed -$8.32K – 5273
2015
Q2 		$8K Buy
+100
New +$6.51K ﹤0.01% 4375

Other funds holding EGRX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AIC
Archer Investment Corporation Carmel, Indiana $469M AUM 19.1% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Group One Trading's EGRX Position: Q4 2024 in Review

Group One Trading sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2024, closing a stake of 785 shares — an estimated $2.93K sold.

Group One Trading first reported a position in EGRX in Q2 2015 and held it in 9 quarters. The position peaked at $653K in Q4 2018. 9 funds tracked by Wall St. Rank hold EGRX as of Q4 2024.

  • Group One Trading reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 785 Eagle Pharmaceuticals, Inc. shares in Q4 2024, an estimated $2.93K.
  • Group One Trading first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 9 quarters.
  • Group One Trading's Eagle Pharmaceuticals, Inc. position peaked at $653K in Q4 2018.
  • 9 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.